Chronic Kidney Disease

Chronic kidney disease (CKD) is a health condition that involves reduced function of the kidneys. There are various causes of reduced kidney function and the severity of the condition can vary greatly.

Chronic Kidney Disease (CKD)

Chronic kidney disease is a health condition that involves the reduced function of the kidneys.

Chronic Kidney Disease Causes

Chronic Kidney Disease Prevention

Investigating the Epidemic for Chronic Kidney Disease

Chronic Kidney Disease Symptoms

Importance of Early Detection for Kidney Disease

Chronic Kidney Disease Diagnosis

Risk Factors for Chronic Kidney Disease

Living with Chronic Kidney Disease

Chronic Kidney Disease Patients and Exercise

Chronic Kidney Disease Treatment

Latest Chronic Kidney Disease News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

GLP-1 agonists are pivotal in obesity care, promoting weight loss and addressing related health issues, with a focus on personalized, holistic treatment.

23 Dec 2025

Simple fruit granola intervention shows promising cardio-renal signals in CKD patients

A single-arm intervention study in Japanese adults with moderate chronic kidney disease found that replacing breakfast with fruit granola for two months lowered systolic blood pressure, reduced LDL-related lipid markers, and decreased a urinary marker of tubular injury. Renal function remained stable, bowel habits improved, and findings were exploratory due to the small, open-label design.

21 Dec 2025

Simple blood test maps hidden Alzheimer’s disease changes

This population-based study used plasma pTau217 to estimate how common Alzheimer’s disease neuropathological changes are across age and cognitive status in a Norwegian community cohort. Prevalence rose steeply with age and was strongly associated with APOE ε4 genotype, education level, and kidney function, with implications for future use of blood biomarkers in clinical practice.

21 Dec 2025

Severe weather exposure increases long-term mortality risk in older adults

Severe weather events have long-term health consequences for vulnerable older adults, according to a study in the Journal of the American Geriatrics Society based on data following Hurricane Harvey.

17 Dec 2025

New data supports link between gum disease and heart disease

There is increasing evidence that gum disease is associated with increased risk of cardiovascular events, including heart attack, stroke, atrial fibrillation, heart failure and cardiometabolic health conditions. Effective prevention and treatment of gum disease, also called periodontal disease, could potentially decrease the burden of cardiovascular disease, according to a new scientific statement published today in the American Heart Association's flagship journal Circulation.

16 Dec 2025

Single-pill combination medications may simplify treatment for adults with high blood pressure

Taking one pill that combines two or more blood pressure medications may help adults with high blood pressure (also known as hypertension) lower their blood pressure level faster and more effectively than taking multiple medications separately, and it may also reduce the risk of heart attack and stroke, according to a new scientific statement published today in the American Heart Association's journal Hypertension.

15 Dec 2025

Exclusive licensing agreement accelerates PHD inhibitor development for anemia in CKD patients

Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and TaiGen Biotechnology, a listed discovery-based and market-focused pharmaceutical company, as well as TaiGen Biopharmaceuticals, its wholly-owned Beijing subsidiary (both referred to as "TaiGen"), today announced an exclusive pipeline out-licensing collaboration.

12 Dec 2025

Lubiprostone shows signs of slowing kidney function decline in chronic kidney disease

In adults with stage IIIb–IV chronic kidney disease, the constipation drug lubiprostone did not reduce gut-derived uremic toxins but preserved creatinine-based kidney function over 24 weeks. The benefit was linked to microbiome remodeling, increased polyamine production, and improved mitochondrial function rather than toxin lowering.

8 Dec 2025

Most Americans still back early hepatitis B vaccination despite policy debate

On December 5, 2025, the Trump administration's Advisory Committee on Immunization Practices (ACIP), whose members were handpicked by Health and Human Services (HHS) Secretary and vaccination critic Robert F. Kennedy Jr., is scheduled to determine whether it should recommend that the Centers for Disease Control and Prevention (CDC) change the recommendation in place since 1991 that newborns be vaccinated against hepatitis B.

5 Dec 2025

Chronic kidney disease accelerates cognitive decline through heart-brain pathways

A new study published in the American Journal of Physiology - Heart and Circulatory Physiology reveals that chronic kidney disease (CKD) accelerates cognitive decline through interconnected damage to the heart and brain-and that these pathways differ markedly between men and women.

4 Dec 2025

Why green tea delivers the strongest health benefits

This review examines tea's health effects, highlighting green tea's benefits for heart health and cognition, and warns about risks in processed tea products.

1 Dec 2025

Study compares the kidney, cardiovascular and mortality risks of three different GLP-1 RAs

Public interest in drugs known as glucagon-like peptide-1 receptor agonists, also called GLP-1 RAs, has surged in recent years, with popular types like semaglutide (sold under brand names like Ozempic and Wegovy) becoming known for their weight-loss effects.

20 Nov 2025

New approach to kidney transplant listing could improve outcomes and equity

The current kidney transplant waitlisting criterion is based on a single measurement of kidney function (estimated glomerular filtration rate [eGFR] ≤20 ml/min/1.73m2) and does not consider an individual's risk of progressing to kidney failure.

13 Nov 2025

Potential breakthrough in treating acute kidney injury with ceramide-targeting drugs

Serious damage to short-term kidney function-known as acute kidney injury, or AKI-can be fatal and also increase the risk of irreversible chronic kidney disease. It can be triggered by stressors ranging from sepsis to heart surgery, and it affects more than half of ICU patients.

12 Nov 2025

Diabetes drugs semaglutide and tirzepatide show real-world heart benefits

In a large real-world analysis across three U.S. healthcare databases, semaglutide and tirzepatide showed cardiovascular benefits consistent with randomized trials. Semaglutide lowered heart attack and stroke risk versus sitagliptin, while tirzepatide performed comparably to dulaglutide and semaglutide over one year.

10 Nov 2025

Expanding the waitlisting criteria for kidney transplantation could improve patient outcomes

The current kidney transplant waitlistingcriterion is based on a single measurement of kidney function (estimated glomerular filtration rate [eGFR] ≤20 ml/min/1.73m2) and does not consider an individual’s risk of progressing to kidney failure.

10 Nov 2025

Using estimated risks and preferences to justify intensive BP control in CKD patients

An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney disease (CKD) would have benefits that outweigh the harm from a systolic blood pressure target of <120 mm Hg compared with a target of <140 mm Hg. The findings will be presented at ASN Kidney Week 2025 November 5– 9.

8 Nov 2025

Preclinical evidence supports sotagliflozin's superior efficacy in attenuating salt-induced kidney damage

Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and kidney- protective effects. In the kidney, SGLT2 reabsorbs approximately 97% offiltered glucose in the S1 and S2 segments of the proximal tubule, while SGLT1reabsorbs the remainder in the S3 segment.

8 Nov 2025

Study shows record surge in reduced kidney function worldwide

Record numbers of men and women globally are now estimated to have reduced kidney function, a new study shows. Figures rose from 378 million people with the disease in 1990 to 788 million in 2023 as the world population grew and aged, making it for the first time a top 10 cause of death worldwide.

8 Nov 2025

New study reveals CKD affects nearly 800 million adults worldwide

The number of adults living with chronic kidney disease (CKD) has more than doubled since 1990, reaching nearly 800 million worldwide, according to new research published in The Lancet. The findings come from the Global Burden of Disease (GBD) 2023 study, which tracked CKD trends among adults age 20 years and older across 204 countries and territories from 1990 through 2023.

7 Nov 2025

Chronic Kidney Disease

Overview

Chronic Kidney Disease Causes

Chronic Kidney Disease Prevention

Investigating the Epidemic for Chronic Kidney Disease

Feature Articles

Chronic Kidney Disease Symptoms

Importance of Early Detection for Kidney Disease

Chronic Kidney Disease Diagnosis

Risk Factors for Chronic Kidney Disease

Living with Chronic Kidney Disease

Chronic Kidney Disease Patients and Exercise

Chronic Kidney Disease Treatment

Latest Chronic Kidney Disease News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Simple fruit granola intervention shows promising cardio-renal signals in CKD patients

Simple blood test maps hidden Alzheimer’s disease changes

Severe weather exposure increases long-term mortality risk in older adults

New data supports link between gum disease and heart disease

Single-pill combination medications may simplify treatment for adults with high blood pressure

Exclusive licensing agreement accelerates PHD inhibitor development for anemia in CKD patients

Lubiprostone shows signs of slowing kidney function decline in chronic kidney disease

Most Americans still back early hepatitis B vaccination despite policy debate

Chronic kidney disease accelerates cognitive decline through heart-brain pathways

Why green tea delivers the strongest health benefits

Study compares the kidney, cardiovascular and mortality risks of three different GLP-1 RAs

New approach to kidney transplant listing could improve outcomes and equity

Potential breakthrough in treating acute kidney injury with ceramide-targeting drugs

Diabetes drugs semaglutide and tirzepatide show real-world heart benefits

Expanding the waitlisting criteria for kidney transplantation could improve patient outcomes

Using estimated risks and preferences to justify intensive BP control in CKD patients

Preclinical evidence supports sotagliflozin's superior efficacy in attenuating salt-induced kidney damage

Study shows record surge in reduced kidney function worldwide

New study reveals CKD affects nearly 800 million adults worldwide

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Chronic Kidney Disease

Overview

Feature Articles

Chronic Kidney Disease Symptoms

Importance of Early Detection for Kidney Disease

Chronic Kidney Disease Diagnosis

Risk Factors for Chronic Kidney Disease

Living with Chronic Kidney Disease

Chronic Kidney Disease Patients and Exercise

Chronic Kidney Disease Treatment

Latest Chronic Kidney Disease News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in